Adrenocortical dysfunction in obesity and the metabolic syndrome

Hormone and Metabolic Research

Volumn 40, Issue 8, 2008, Pages 515-517

  Krug, A W ^a,b   Ehrhart Bornstein, M ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Adrenal glands; Aldosterone; Arterial hypertension; Metabolic syndrome; Obesity

Indexed keywords

ADIPOCYTOKINE; ALDOSTERONE; ANGIOTENSIN II; CORTICOSTEROID; LIPID; MINERALOCORTICOID;

ADIPOSE TISSUE; ADRENAL CORTEX INSUFFICIENCY; ALDOSTERONE BLOOD LEVEL; CYTOKINE RELEASE; ENERGY BALANCE; HUMAN; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; REGULATORY MECHANISM; SHORT SURVEY; STEROIDOGENESIS;

ADRENAL CORTEX; ADRENAL MEDULLA; ALDOSTERONE; HUMANS; METABOLIC SYNDROME X; OBESITY;

EID: 50249104779     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1073154     Document Type: Short Survey

References (36)

1. Seeman TE, Robbins RJ. Aging and hypothalamic-pituitary-adrenal response to challenge in humans. Endocr Rev 1994; 15: 233-260
2. Zacharowski K, Zacharowski PA, Koch A, Baban A, Tran N, Berkels R, Papewalis C, Schulze-Osthoff K, Knuefermann P. Zahringer U, Schumann RR, Rettori V, MacCann SM, Bornstein SR. Toll-like receptor 4 plays a crucial role in the immune-adrenal response to systemic inflammatory response syndrome. Proc Natl Acad Sci USA 2006:103: 6392-6397
3. Bornstein SR, Ziegler CG, Krug AW, Kanckowski W, Rettori V, MacCann SM, Wirth M, Zacharowski K. The role of toll-like receptors in the immuneadrenal crosstalk. Ann N Y Acad Sci 2006; 1088: 307-318
4. Bateman A, Singh A, Kral T, Solomon S. The immune-hypothalamic- pituitary-adrenal axis. Endocr Rev 1989; 10: 92-112
5. Kyrou I, Tsigos C. Stress mechanisms and metabolic complications. Horm Metab Res 2007; 39: 430-438
6. Bornstein SR, Uhlmann K, Haidan A, Ehrhart-Bornstein M, Scherbaum WA. Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland. Leptin inhibits Cortisol release directly. Diabetes 1997; 46:1235-1238
7. Johren O, Bruggemann N, Dominiak P. Orexins (hypocretins) and adrenal function. Horm Metab Res 2004; 36: 370-375
8. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992; 267: 1244-1252
9. Bornstein SR, Schuppenies A, Wong ML, Licinio J. Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions. Mol Psychiatry 2006; 11: 892-902
10. Korenblum W, Barthel A, Licinio J, Wong ML, Wolf OT, Kirschbaum C, Bornstein SR. Elevated Cortisol levels and increased rates of diabetes and mood symptoms in Soviet Union-born Jewish immigrants to Germany. Mol Psychiatry 2005; 10: 974-975
11. Hanefeld M, Ceriello A, Schwarz PE, Bornstein SR. The challenge of the metabolic syndrome. Horm Metab Res 2007; 39: 625-626
12. Lamounier-Zepter V, Ehrhart-Bornstein M, Bornstein SR. Metabolic syndrome and the endocrine stress system. Horm Metab Res 2006; 38: 437-441
13. Salehi A, Ferenczi B, Zumoff B. Obesity and Cortisol Status. Horm Metab Res 2005; 37: 193-197
14. Grundy SM, Cleeman Jl. Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith JrSC, Spertus JA, Costa F. American Heart Association; National Heart. Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart. Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752
15. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110: 1245-1250
16. Hanefeld M, Ceriello A, Schwarz PE, Bornstein SR. The metabolic syndrome - a postprandial disease? Horm Metab Res 2006; 38: 435-436
17. Cohn JN, Colucci W. Cardiovascular effects of aldosterone and post-acute myocardial infarction pathophysiology. Am J Cardiol 2006; 97: 4F-12F
18. Schiffrin EL. Effects of aldosterone on the vasculature. Hypertension 2006; 47: 312-318
19. Glider G, Bauersachs J, Frantz S, Weismann D, Allolio B, Ertl G, Angermann CE, Stork S. Complementary and incremental mortality risk prediction by Cortisol and aldosterone in chronic heart failure. Circulation 2007; 115: 1754-1761
20. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341: 709-717
21. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M. Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309-1321
22. Kidambi S, Kotchen JM, Grim CE, Raff H, Mao J, Singh RJ, Kotchen TA. Association of adrenal steroids with hypertension and the metabolic syndrome in blacks. Hypertension 2007; 49: 704-711
23. Bochud M, Nussberger J, Bovet P, Maillard MR, Elston RC, Paccaud F, Shamlaye C, Burnier M. Plasma aldosterone is independently associated with the metabolic syndrome. Hypertension 2006; 48: 239-245
24. Lamounier-Zepter V, Rotthoff T, Ansurudeen I, Kopprasch S, Scherbaum WA, Ehrhart-Bornstein M, Bornstein SR. Increased aldosterone/renin quotient in obese. Horm Metab Res 2006; 38: 471-475
25. Bentley-Lewis R, Adler G, Perlstein T, Seely EW, Hopkins PN, Williams GH, Garg R. Body Mass Index predicts aldosterone production in normotensive adults on a high-salt diet. J Clin Endocrinol Metab 2007; 92: 4472-4475
26. Krug AW, Ehrhart-Bornstein M. Newly discovered endocrine functions of white adipose tissue: possible relevance in obesity-related diseases. Cell Mol Life Sci 2005; 62: 1359-1362
27. Fischer-Posovszky P, Wabitsch M, Hochberg Z. Endocrinology of adipose tissue - an update. Horm Metab Res 2007; 39: 314-321
28. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A, Hauner H, MacCann SM, Scherbaum WA, Bornstein SR. Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci USA 2003; 100: 14211-14216
29. Ehrhart-Bornstein M, Arakelyan K, Krug AW, Scherbaum WA, Bornstein SR. Fat cells may be the obesity-hypertension link: human adipogenic factors stimulate aldosterone secretion from adrenocortical cells. Endocr Res 2004; 30: 865-870
30. Krug AW, Vleugels K, Schinner S, Lamounier-Zepter V, Ziegler CG, Bornstein SR, Ehrhart-Bornstein M. Human adipocytes induce an ERK1/2 MAP kinases-mediated upregulation of steroidogenic acute regulatory protein (StAR) and an angiotensin II - sensitization in human adrenocortical cells. Int J Obes (Lond) 2007; 31: 1605-1616
31. Ansurudeen I, Kopprasch S, Ehrhart-Bornstein M, Willenberg HS, Krug AW, Funk RH, Bornstein SR. Vascular-adrenal niche-endothelial cell-mediated sensitization of human adrenocortical cells to angiotensin II. Horm Metab Res 2006; 38: 476-480
32. Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, Katch V, Martin M. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 1989 Aug 31; 321: 580-585
33. Egan BM, Stepniakowski K, Goodfriend TL. Am J Hypertens 1994; 7: 886-893
34. El-Gharbawy AH, Nadig VS, Kotchen JM, Grim CE, Sagar KB, Kaldunski M, Hamet P, Pausova Z, Gaudet D, Gossard F, Kotchen TA. Arterial pressure, left ventricular mass, and aldosterone in essential hypertension. Hypertension 2001; 37: 845-850
35. Nagase M, Yoshida S, Shibata S, Nagase T, Gotoda T, Ando K, Fujita T. Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. J Am Soc Nephrol 2006; 17: 3438-3446
36. Rahmouni K, Correia ML, Haynes WG, Mark AL. Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005; 45: 9-14